BIG PHARMA WATCH: DRUG MAKERS FUNNEL HUNDREDS OF MILLIONS TO NON-PROFIT GROUPS IN STEALTHY LOBBYING CAMPAIGN

10-8-2019 Blog Posts

In yet another example of how Big Pharma attempts to game the system, Bloomberg Government reports that six of the industry’s top brand name drug manufacturers “funneled more than $680 million into hundreds of nonprofits last year, including many now campaigning against federal legislation to tackle the rising cost of medicine.” And while donating to […]

New Study: Big Pharma Hikes Prices Without Improving Their Drugs

10-8-2019 Blog Posts

Unjustified Price Increases Cost Patients And Health Plans Billions Big Pharma repeatedly hikes prices on brand name drugs without making any improvements to those medications. That’s the finding of a new analysis conducted by the Institute for Clinical and Economic Review (ICER). The report found that drug companies hiked prices on seven popular drugs in […]

THEY SAID IT! HOUSE LAWMAKERS MAINTAIN COMMITMENT TO BIPARTISAN COOPERATION ON DRUG PRICING

09-26-2019 Blog Posts

House E&C Health Subcommittee Reiterate Need for Action to Hold Big Pharma Accountable, Deliver Relief for American Patients The U.S. House Energy and Commerce Subcommittee on Health held a hearing Wednesday on the drug pricing package put forward by Speaker Pelosi earlier this week. During the hearing, lawmakers from both sides of the aisle expressed […]

ICYMI: An Unprecedented Opportunity for Washington to Lower Drug Prices

09-25-2019 Blog Posts

An Unprecedented Opportunity for Washington to Lower Drug Prices Lauren Aronson The Hill Congress was gaveled back into session this month with unprecedented momentum behind legislative efforts to hold Big Pharma accountable and lower prescription drug prices. An array of key factors are aligned that make now the time that lawmakers simply must act to […]

THEY SAID IT! LAWMAKERS SLAM BIG PHARMA FOR “GAMING THE SYSTEM” TO BLOCK COMPETITION

09-20-2019 Blog Posts

Members of E&C Consumer Protection Subcommittee Call for Bipartisan Action to Hold Brand Name Drug Makers Accountable   The U.S. House Energy & Commerce Subcommittee on Consumer Protection & Commerce held a hearing on “Exposing How Pharmaceutical Companies Game The System” on Thursday. During the hearing, lawmakers called out Big Pharma for a number of […]

Big Pharma Watch: Drug Maker Hit With $15 Million Penalty for Illegal Price Hike Scheme

09-10-2019 Blog Posts

In case you missed it, a recent article in HealthLeaders details how brand name drug maker Mallinckrodt used a foundation to secretly hike the price of the drug Acthar from $50 to $32,200 over a 13-year period, all while marketing the drug as ‘free’ in an illegal kickback scheme. The company used kickbacks in the […]

Going Boldly To The Bottom: Poll Finds Opinion Of Big Pharma Hits Record Low

09-3-2019 Blog Posts

Americans Have Negative View of Drug Makers by Two-to-One Margin, Worst of Any Industry And the winner of this year’s most poorly regarded U.S. industry?  We’ll give you a hint.  It’s not oil and gas, big banks or even the federal government – it’s Big Pharma.  A new poll released this morning from Gallup finds […]

What They Are Saying: Americans Urge Action to Lower Drug Prices, Hold Big Pharma Accountable

08-29-2019 Blog Posts

Voices From Around the Country Call for Congress to Pass Senate Finance Package Americans across the country are urging Congress to hold Big Pharma accountable and lower prescription drug prices by passing The Prescription Drug Pricing Reduction Act Of 2019. This bipartisan, market-based legislative package marks an important first step towards tackling the crisis of […]

Big Pharma Watch: How Drug Makers Use Charities to Pad Their Bottom Line

08-29-2019 Blog Posts

In case you missed it, a recent article in The Economist digs into the inner workings of Big Pharma-backed charities and how the industry uses them as a vehicle to boost their bottom line. These charities create the illusion that they’re helping make costly drugs more accessible for patients, but in reality Big Pharma’s generosity […]

Big Pharma Watch: Drug Makers Tone Deaf on Crisis of Affordability

08-22-2019 Blog Posts

BIO CEO Says Prescription Drugs Are Not Too Expensive If you needed any more evidence that Big Pharma is tone deaf to the growing crisis of rising prescription drug prices, look no further than a Tuesday C-SPAN interview with BIO President and CEO Jim Greenwood. During the interview, on C-SPAN’s “Washington Journal” program, Greenwood answers […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.